MONDAY, July 6 (HealthDay News) -- The drug Alimta (pemetrexed) has been approved by the U.S. Food and Drug Administration to prevent progression of certain types of advanced or metastatic (spreading) lung cancer, the agency said Monday.
Latest Cancer News
The drug is produced by Indianpolis-based Eli Lilly & Co.
-- Scott Roberts
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Subscribe to MedicineNet's Cancer Report Newsletter